These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35917044)

  • 1. Visualizing Sphingosine-1-Phosphate Receptor 1(S1P
    Hashemi E; Yoseph E; Tsai HC; Moreno M; Yeh LH; Mehta SB; Kono M; Proia R; Han MH
    Cell Mol Neurobiol; 2023 Apr; 43(3):1219-1236. PubMed ID: 35917044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5.
    Selkirk JV; Dines KC; Yan YG; Ching N; Dalvie D; Biswas S; Bortolato A; Schkeryantz JM; Lopez C; Ruiz I; Hargreaves R
    J Pharmacol Exp Ther; 2021 Dec; 379(3):386-399. PubMed ID: 34535564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.
    Guglielmetti C; Praet J; Rangarajan JR; Vreys R; De Vocht N; Maes F; Verhoye M; Ponsaerts P; Van der Linden A
    Neuroimage; 2014 Feb; 86():99-110. PubMed ID: 23933305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine kinase 2 is essential for remyelination following cuprizone intoxication.
    Song H; McEwen HP; Duncan T; Lee JY; Teo JD; Don AS
    Glia; 2021 Dec; 69(12):2863-2881. PubMed ID: 34399014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation.
    Willems E; Schepers M; Piccart E; Wolfs E; Hellings N; Ait-Tihyaty M; Vanmierlo T
    FASEB J; 2024 Jan; 38(2):e23413. PubMed ID: 38243760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.
    Kim HJ; Miron VE; Dukala D; Proia RL; Ludwin SK; Traka M; Antel JP; Soliven B
    FASEB J; 2011 May; 25(5):1509-18. PubMed ID: 21248243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
    Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
    J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P
    Kihara Y; Jonnalagadda D; Zhu Y; Ray M; Ngo T; Palmer C; Rivera R; Chun J
    FASEB J; 2022 Feb; 36(2):e22132. PubMed ID: 34986275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
    Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
    Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
    Groves A; Kihara Y; Chun J
    J Neurol Sci; 2013 May; 328(1-2):9-18. PubMed ID: 23518370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways.
    Ryu JM; Baek YB; Shin MS; Park JH; Park SH; Lee JH; Han HJ
    Stem Cell Res; 2014 Jan; 12(1):69-85. PubMed ID: 24145189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.
    Miron VE; Ludwin SK; Darlington PJ; Jarjour AA; Soliven B; Kennedy TE; Antel JP
    Am J Pathol; 2010 Jun; 176(6):2682-94. PubMed ID: 20413685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis.
    Sic H; Kraus H; Madl J; Flittner KA; von Münchow AL; Pieper K; Rizzi M; Kienzler AK; Ayata K; Rauer S; Kleuser B; Salzer U; Burger M; Zirlik K; Lougaris V; Plebani A; Römer W; Loeffler C; Scaramuzza S; Villa A; Noguchi E; Grimbacher B; Eibel H
    J Allergy Clin Immunol; 2014 Aug; 134(2):420-8. PubMed ID: 24679343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.
    Gatfield J; Monnier L; Studer R; Bolli MH; Steiner B; Nayler O
    Cell Signal; 2014 Jul; 26(7):1576-88. PubMed ID: 24704119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model.
    Nystad AE; Lereim RR; Wergeland S; Oveland E; Myhr KM; Bø L; Torkildsen Ø
    J Neuroimmunol; 2020 Feb; 339():577091. PubMed ID: 31739156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Use the Cuprizone Model to Study De- and Remyelination.
    Kipp M
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
    Patel JR; Williams JL; Muccigrosso MM; Liu L; Sun T; Rubin JB; Klein RS
    Acta Neuropathol; 2012 Dec; 124(6):847-60. PubMed ID: 22933014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrosomal nanocurcumin promotes remyelination through induction of oligodendrogenesis in experimental demyelination animal model.
    Motavaf M; Sadeghizadeh M; Babashah S; Zare L; Javan M
    J Tissue Eng Regen Med; 2020 Oct; 14(10):1449-1464. PubMed ID: 32750189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
    Brinkmann V
    Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.